It's all change at Alphabet's life sciences business Verily, with a $1 billion funding round and a shake-up of its senior leadership, including a new chief executive and executive chairman, who ...

In 2021, the pair teamed up with Verily, the healthcare subsidiary of Google owner Alphabet, to run the pivotal Mirai study of Rejoyn in 286 people with MDD.